Microarrays have recently been used to discover that what appeared to be a single type of lymphoma was actually a mixture of two cancer subtypes at the molecular level. CGAP cancer researchers then discovered that only one subtype gave the best overall response. New treatment strategies must be developed to improve response for all subtypes of cancer.
![CGAP Helps Cancer Research in the Clinic: Differentiating Between Cancers with Similar Clinical Symptoms](https://webarchive.library.unt.edu/eot2008/20090131033222im_/http://newscenter.cancer.gov/images/Documents/5d8fef4b-34da-44ba-8087-191d81c95c88/cancer24.jpg)
< Previous | Index | Next Slide > |